Literature DB >> 24972325

Differences in MBL levels between juvenile patients newly diagnosed with type 1 diabetes and their healthy siblings.

Stine Møller Sildorf1, Stefanie Eising2, David M Hougaard3, Henrik Bindesbøl Mortensen4, Kristin Skogstrand3, Flemming Pociot4, Jesper Johannesen4, Jannet Svensson4.   

Abstract

The incidence of type 1 diabetes (T1D) has during the last few decades been increasing in children and juveniles. Multi-factorial courses combining genetic disposition and environmental factors might be in play, and through the years, there has been a mounting interest in the innate immune system's role in the development of T1D. The aim of this study was to determine mannose binding lectin (MBL) levels in newly diagnosed children with T1D (n=481) over a period of 10 years (1997-2005) and to compare these levels with corresponding levels in their healthy siblings (n=479). Furthermore, the aims were to evaluate if MBL-levels in patients and siblings were influenced by season, age autoimmunity and/or changed over time. The study found that MBL levels differed between patients and their healthy siblings when adjusted for age, gender, season and period. More patients than siblings had MBL levels above 0.8 μg/ml, associated with high producing MBL genotypes, and the elevated MBL levels were associated with high levels of four T1D related cytokines (IL-1β, IL-12, IL-18 and TNF-α). MBL levels increased during the study period and siblings had seasonal variance in concentrations with the lowest level during wintertime (Dec-Feb). In conclusion, more patients than siblings had a high MBL level, and high levels of MBL were related to high levels of T1D specific cytokines, supporting a role of the innate immune system and MBL on the risk of developing T1D.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Cytokines; Innate immune system; Mannose binding lectin; Pediatrics; Type 1 diabetes

Mesh:

Substances:

Year:  2014        PMID: 24972325     DOI: 10.1016/j.molimm.2014.06.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  4 in total

1.  MASP1, THBS1, GPLD1 and ApoA-IV are novel biomarkers associated with prediabetes: the KORA F4 study.

Authors:  Christine von Toerne; Cornelia Huth; Tonia de Las Heras Gala; Florian Kronenberg; Christian Herder; Wolfgang Koenig; Christa Meisinger; Wolfgang Rathmann; Melanie Waldenberger; Michael Roden; Annette Peters; Barbara Thorand; Stefanie M Hauck
Journal:  Diabetologia       Date:  2016-06-25       Impact factor: 10.122

2.  Association between Neonatal Whole Blood Iron Content and Cytokines, Adipokines, and Other Immune Response Proteins.

Authors:  Steffen U Thorsen; Christian B Pipper; Christina Ellervik; Flemming Pociot; Julie N Kyvsgaard; Jannet Svensson
Journal:  Nutrients       Date:  2019-03-04       Impact factor: 5.717

3.  Simultaneous pancreas-kidney transplantation in patients with type 1 diabetes reverses elevated MBL levels in association with MBL2 genotype and VEGF expression.

Authors:  Roel Bijkerk; Pieter van der Pol; Meriem Khairoun; Danielle J van Gijlswijk-Jansen; Ellen Lievers; Aiko P J de Vries; Eelco J de Koning; Hans W de Fijter; Dave L Roelen; Rolf H A M Vossen; Anton Jan van Zonneveld; Cees van Kooten; Marlies E J Reinders
Journal:  Diabetologia       Date:  2016-01-15       Impact factor: 10.122

4.  Confirmation and Identification of Biomarkers Implicating Environmental Triggers in the Pathogenesis of Type 1 Diabetes.

Authors:  Robert Z Harms; Katie R Ostlund; Monina S Cabrera; Earline Edwards; Marisa Fisher; Nora Sarvetnick
Journal:  Front Immunol       Date:  2020-09-15       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.